Beyond the label: ethical and clinical implications of off-label drug use in pediatric emergency care. [PDF]
Ital J PediatrColombo M, Plebani A, Agosti M.
europepmc +1 more source
Postmarketing analysis of sotatercept: identifying serious unlabelled events. [PDF]
Open HeartCao Z, Xiao Q, Li X, Zhang H, Zhang M.
europepmc +1 more source
Postmarketing Research for Opioid Abuse-Deterrent Formulations: A Narrative Review. [PDF]
J Pain ResWebster L, Gudin J, Green JL, Argoff CE.
europepmc +1 more source
Safety Evaluation of Omniscan: An Observational Postmarketing Surveillance. [PDF]
CureusMahajan H +9 more
europepmc +1 more source
From a pyramid to an amphitheatre (triangle to circle): embracing the totality of evidence for the postmarketing evaluation of the safety of therapeutic interventions. [PDF]
BMJ OpenShakir S, Lane S.
europepmc +1 more source
FDA Adverse Event Reporting System (FAERS) Essentials: A Guide to Understanding, Applying, and Interpreting Adverse Event Data Reported to FAERS. [PDF]
Clin Pharmacol TherPotter E, Reyes M, Naples J, Dal Pan G.
europepmc +1 more source
Getting There First With the Best: The Need to Shorten the Prescription Drug Approval Process [PDF]
, 2011 Kassel, Mark A.
core +1 more source
Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System database. [PDF]
Ther Adv Drug SafXiong X, Chen Z, Yan B.
europepmc +1 more source
Evolution of biological agents: how established drugs can become less safe [PDF]
, 2017 Casadevall, Nicole +2 more
core +1 more source
Safety and Performance of Postmarketing Breast Implants: An Integrated Review with Technovigilance Data. [PDF]
J Clin MedRamalho AAL +8 more
europepmc +1 more source